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Hyaluronate lyase contributes directly to bacterial in-
vasion by degrading hyaluronan, the major component
of host extracellular matrix of connective tissues. Strep-
tococcus pneumoniae hyaluronate lyase (SpnHL) is built
from two structural domains that interact through in-
terface residues, in addition to being connected by a
peptide linker. For the first time we demonstrate that
the N- and C-terminal domains of SpnHL fold/unfold
independent of each other suggesting the absence of any
significant cooperative interactions between them. The
C-terminal domain of SpnHL is less stable than the N-
terminal domain against thermal and guanidine hydro-
chloride denaturation. The intact N-terminal domain
was purified after limited proteolysis of SpnHL under
conditions where only the C-terminal domain was un-
folded. Isolated N-terminal domain of SpnHL had simi-
lar thermal stability as when present in the native en-
zyme and was found to be enzymatically active
demonstrating that it is capable of carrying out enzy-
matic reaction on its own. Functional studies demon-
strated that guanidine hydrochloride, guanidine iso-
thiocyanate, L-arginine methyl ester, and L-arginine
inhibit the enzymatic activity of SpnHL at very low con-
centrations. This provides a lead for new chemical enti-
ties that can be exploited for designing effective inhib-
itors of SpnHL.
Streptococcus pneumoniae is a major human pathogen that
colonizes predominantly in the upper respiratory tract of hu-
mans. It is one of the key causes of life threatening disease such
as pneumonia, bacteremia, and meningitis (1) and less danger-
ous but significantly more prevalent diseases like sinusitis or
otitis media (2). The groups of human population especially
affected by this organism are infants, the elderly, and immu-
nocompromised individuals (3, 4).
Hyaluronidases constitute a special group of polysaccharide-
degrading enzymes that have the ability to degrade primarily
hyaluronan (HA),1 yielding various lengths of oligosaccharides
as the end product (5). The bacterial hyaluronidases are called
hyaluronate lyase. Various Gram-positive microorganisms in-
cluding species of Streptococcus, Clostridium, Propionibacte-
rium, Staphylococcus, and Peptostreptococcus produce hyaluro-
nate lyase (6). This enzyme is either cell-associated or released
outside of cell. It primarily degrades hyaluronan and certain
chondroitin sulfates, the major components of host extracellu-
lar matrix of tissue (5, 7, 8). The HA degradation directly
contributes to bacterial invasion by allowing greater microbial
access to, or migration between, host tissues for colonization (8,
9). Because of this reason hyaluronate lyase is also being called
“spreading factor.” The protein sequence of four bacterial hya-
luronate lyase from S. pneumoniae (10), Streptococcus agalac-
tiae (11), Staphylococcus aureus (12), and Propionibacterium
acnes (13) have been reported so far. Their sequence homolo-
gies range from 28 to 68% suggesting their structural, func-
tional, and evolutionary similarities.
The crystal structure of S. pneumoniae hyaluronate lyase
(SpnHL) shows that the enzyme is built up of two domains, an
N-terminal domain or catalytic domain, which is predomi-
nantly -helical, and a C-terminal domain or the supportive
domain, which is predominantly -sheet (14). The two domains
are connected by a short linker polypeptide. The interface be-
tween the N- and C- terminal domains is composed of several
residues from the two domains forming several interactions.
The cleft in between the - and -domains is the place where
the HA binding and degradation occurs and is wide at the two
ends and narrower in the middle. The crystal structure of S.
agalactiae hyaluronate lyase is similar to SpnHL in whole
structure architecture and active site geometry except that it
has an additional -sheet domain before the N-terminal -do-
main present in the SpnHL (15).
Although crystal structure of hyaluronate lyase and S. aga-
lactiae in complex with HA has been reported (14–16), detailed
insight into important structural features like existence of
co-operative interactions between C- and N-terminal domains
and the specific role of C-terminal domain in functional activity
of SpnHL have not been provided so far. Besides this, despite
the importance of SpnHL in pneumococcal infection no sincere
efforts to search suitable inhibitors for this enzyme have been
made (5, 17).
We report detailed studies on the structural changes associ-
ated with the thermal denaturation and guanidine hydrochlo-
ride-, calcium chloride-, and magnesium chloride-induced un-
folding of SpnHL using optical spectroscopic techniques,
limited proteolysis, and enzymatic activity measurements. The
N-terminal domain of SpnHL was isolated and purified after
limited proteolysis. Comparative analysis of enzymatic activity
and stability of the isolated N-terminal domain of SpnHL with
that when present along with C-terminal in the native enzyme
have also been reported. Furthermore, efficiency of guanidine
hydrochloride (GdnHCl), L-arginine, L-arginine methyl ester
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(L-NAME), and guanidine isothiocyanate (GdnHSCN) as inhib-
itors of SpnHL has also been studied.
EXPERIMENTAL PROCEDURES
Cloning of SpnHL—S. pneumoniae culture growth and the chromo-
somal DNA extraction were carried out as described previously (18). An
internal gene fragment of SpnHL encoding functional hyaluronate
lyase (19) was amplified by polymerase chain reaction. The different
oligonucleotides (prepared based on the earlier reported gene sequence;
GenBankTM accession number L20670) used were upstream, 5-
CTAGCTAGCGTTAAGGATACATACACAGACCGT and downstream,
5-CCGCTCGAGTGCCTGCTCTAGTTTTTTAAAGAC for with C(6) his-
tidine-tag and 5-CCGCTCGAGTTATGCCTGCTCTAGTTTTTTAAA-
GAC for without histidine-tagged protein. Reactions were carried out in
two phases for five and 30 cycles in a total volume of 50 l with 2 units
of Deep vent polymerase. The first five cycles for without overhang
amplification was 94 °C, 30 s; 46.5 °C, 1 min; 72 °C, 3 min; and the
second 30 cycles for with overhang amplification was 94 °C, 30 s;
56.5 °C, 1 min; 72 °C, 3 min with the final extension of 10 min. This
amplified gene fragment was cloned into pET 21-d between NheI and
XhoI sites. DNA sequencing confirmed the homogeneity of sequence.
The resulting construct was transformed into BL21(DE3).
Overexpression and Purification—Overexpression and purification
for histidine-tagged protein was carried out as described earlier (18).
Purification of non histidine-tagged protein was carried out using var-
ious chromatographic techniques. Briefly, an overnight culture was
harvested, and the cell pellet was resuspended in 20 mM Tris-Cl, pH 7.4,
containing 2 mM EDTA. After sonication the cell lysate was loaded onto
Mono-Q pre-equilibrated with the same buffer. The column was washed
with the same buffer containing 100 mM NaCl, and the protein was
eluted with the linear gradient of buffer containing 100–500 mM NaCl.
The fractions containing SpnHL was pooled, and ammonium sulfate
was added to a final concentration of 1.7 M. The protein solution was
loaded onto phenyl-Sepharose (high substituted) pre-equilibrated with
the same buffer containing 1.7 M ammonium sulfate. The protein was
eluted using a linear gradient of 1.7 to 0 M ammonium sulfate. The
active fractions were pooled, concentrated, and finally purified on a
Superdex 200 HR 10/30 column on AKTA fast protein liquid chroma-
tography equilibrated with the same buffer without ammonium sulfate.
Eluted protein was finally concentrated, dialyzed against the 20 mM
Tris-HCl, pH 7.4, and stored as a 10 mg/ml stock solution at 4 °C. The
purity of purified enzyme was checked by electrospray ionization mass
spectrometry and found to be 99% pure. The final purified protein
sample was also subjected to the N-terminal protein sequencing.
Denaturation/Unfolding of SpnHL—SpnHL (1 M) was incubated in
the presence/absence of increasing concentration of GdnHCl or CaCl2 or
MgCl2 and incubated for 1 h at 25 °C before taking the measurements.
Initial studies were carried out with both the histidine-tagged and
non-histidine-tagged enzyme. Similar results were obtained with both
enzymes, so only histidine-tagged enzyme was used for further studies,
as it was easy to purify.
Assay of Enzymatic Activity—The activity of SpnHL is defined as its
ability to breakdown HA to unsaturated disaccharide units (20). In a
1-ml solution of 0.2 mg/ml HA in 50 mM sodium acetate buffer, 10 mM
CaCl2, pH 6.0 (or the different salt concentration was maintained in the
HA solution), 10 l of enzyme sample (4 ng/l, diluted just before taking
measurement or stated otherwise) was added. The reaction mixture
was incubated for 5 min during which the measurements were carried
out by monitoring the increase in absorbance at 232 nm at 25 °C.
Percent inhibition was determined as described previously (17).
Fluorescence Spectroscopy—Fluorescence spectra were recorded with
a PerkinElmer Life Sciences LS 50B spectroluminesencemeter in a
5-mm path length quartz cell at 25 °C. For monitoring tryptophan
fluorescence, excitation wavelength of 290 was used, and the spectra
were recorded between 300 and 400 nm.
Circular Dichroism Measurements—CD measurements were made
with a Jasco J800 spectropolarimeter calibrated with ammonium ()-
10-camphorsulfonate. The results are expressed as the mean residual
ellipticity [], which is defined as []  100  obs/(lc), where obs is the
observed ellipticity in degrees, c is the concentration in moles of residue
per liter, and l is the length of the light path in centimeters. The values
obtained were normalized by subtracting the base line recorded for the
buffer having the same concentration of denaturant or salt under sim-
ilar conditions.
Limited Proteolysis—SpnHL (0.2 mg/ml) incubated for 1 h under
specified conditions was subjected to limited proteolysis with car-
boxypeptidase B under similar conditions like at 55 °C or in the pres-
ence of 0.75 M GdnHCl or 1.5 M CaCl2 at 25 °C for 15 min. A protease to
enzyme ratio of 1:100 (w/w) was used for the study. The protease
reaction was stopped by adding 2 mM EDTA to reaction mixture, and
the samples were analyzed on 10% SDS-PAGE.
Size-exclusion Chromatography—Gel filtration experiments were
carried out on a Superdex 200 HR 10/30 column and Sephadex 75 HR
10/30 column on AKTA fast protein liquid chromatography (Amersham
Biosciences) for the purification of native SpnHL and the N-terminal
domain, respectively. Column was calibrated with various molecular
weight standard markers (Amersham Biosciences) before use. Column
was equilibrated and run with 20 mM Tris-HCl, pH 7.4, at 25 °C. 200 l
of the sample was loaded on the column and run at 25 °C, flow rate of
0.3 ml/min, with detection at 280 nm.
RESULTS AND DISCUSSION
The crystal structure of SpnHL shows that the enzyme is
made of two distinct structural domains connected by a short
polypeptide linker. Both the domains are spherical and of ap-
proximately the same size of about 41 kDa (14). The N-terminal
-helical domain (-domain) contains the first 361 residues
(Lys171–Ser531) of the enzyme and is composed of 13 -helices
connected by 12 loops. An 11-residue linker (Asp532–Ser542) is
located between the two structural domains. The C-terminal
-sheet domain (-domain) contains the following 347 residues
(Tyr543–Lys889) and is composed of 24 -strands, four short
-helices, and 25 connecting loops. The interface between the
N- and C-terminal domains is 1776 Å2 in area and is composed
of 37 residues from the N-terminal domain and 34 residues
from the C-terminal domain forming about 343 interactions.
For analyzing the cooperative interactions existing between
the two structural domains of SpnHL we first studied the
FIG. 1. Thermal unfolding profile of
native SpnHL measured by CD ellip-
ticity at 222 nm. The data are repre-
sented as percentages with the value ob-
served for native enzyme taken as 100%.
The experimental details are given under
“Experimental Procedures.”
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relative stability of the N- and C-terminal domains by carrying
out thermal- and GdnHCl-induced denaturation of enzyme.
The Two Structural Domains of SpnHL Have
Significantly Different Stabilities
Thermal Denaturation—The thermal unfolding of SpnHL
was characterized by monitoring the loss of secondary struc-
ture of enzyme with temperature. Fig. 1 summarizes the
changes in ellipticity at 222 nm of SpnHL at increasing tem-
perature, where two distinct transitions were observed be-
tween 20 and 100 °C. These transitions were in the tempera-
ture regions from 35 to 60 °C and 65 to 100 °C and centered at
about 50 and 82 °C, respectively. Furthermore, the transitions
were found to be reversible as they were also observed on
cooling the SpnHL samples from 100 to 20 °C after the heating
scan (data not shown). These observations suggest that the
SpnHL molecule contains two distinct structural domains of
significantly different thermal stabilities.
Guanidine Hydrochloride Unfolding—The guanidine hydro-
chloride-induced changes in the structural properties of SpnHL
were studied using optical spectroscopic techniques. Time-de-
pendent changes in structural parameters of SpnHL at increas-
ing concentrations of GdnHCl showed maximum changes
within 1 h of incubation and no further alteration up to the next
12 h (data not shown) suggesting that incubation time of 1 h is
sufficient for achieving equilibrium under any GdnHCl concen-
tration studied.
The GdnHCl-induced alterations in the tertiary structure of
SpnHL were monitored by studying the changes in the trypto-
phan fluorescence of enzyme at increasing concentration of
GdnHCl. If a significant difference exists between the fluores-
cence emission maxima of native and denatured protein, co-
relation between the GdnHCl concentration and the functional
changes in wavelength at which fluorescence emission is max-
imal provides useful information on the stabilization of inter-
mediates during protein unfolding (21). For SpnHL, the emis-
sion wavelength maximum in the absence of GdnHCl (fo) and at
GdnHCl concentration greater than 2.5 M (fd) were 334 and 355
nm, respectively. The fractional change in wavelength at which
the tryptophan fluorescence emission spectrum of SpnHL is
maximal is plotted against the concentration of GdnHCl in Fig.
2A. Two well separated transitions were observed on increas-
FIG. 2. Guanidine hydrochloride-in-
duced unfolding of SpnHL at 25 °C. A,
plot of fractional changes in wavelength
of maximum fluorescence emission of
tryptophan molecules in SpnHL, (fi  f0)/
(fd  f0), versus GdnHCl concentration. fi
is the wavelength for a particular sample,
f0 is the wavelength in absence of
GdnHCl, and fd is wavelength at GdnHCl
concentration of or greater than 2.5 M.
The filled symbols represent data for gua-
nidine hydrochloride, and the open sym-
bols represent that for NaCl. B, GdnHCl-
induced changes in secondary structure of
SpnHL as monitored by following changes
in the CD ellipticity value at 222 nm. The
data are represented as percentages with
the value observed for native enzymes in
absence of GdnHCl taken as 100%. The
symbols are the same as in A. C, thermal
unfolding of 0.75 M GdnHCl-treated
SpnHL measured by CD ellipticity at 222
nm. The data are represented as percent-
ages with the value observed for 0.75 M
GdnHCl at 20 °C taken as 100%. The en-
zyme was incubated in 0.75 M GdnHCl for
1 h at 20 °C, after which the measure-
ments were made.
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ing the GdnHCl concentration between 0 and 2.5 M. The first
transition was very sharp and occurred between 0.4 and 0.7 M
GdnHCl. A plateau region existed between 0.7 and 0.9 M and
was followed by a broad second transition between 0.9 and 2 M
GdnHCl. Furthermore, the changes in emission wavelength
associated with the first transition was only from 334 to 341
nm, suggesting that only partial unfolding of the SpnHL mol-
ecule is associated with the first transition. At 2 M GdnHCl, an
emission wavelength of 355 nm was observed indicating that
all the tryptophan moieties present in the SpnHL are exposed
to solvent under these conditions (22). Such a situation can
arise only when the protein is completely unfolded.
The effect of GdnHCl on the secondary structure of SpnHL
was studied by monitoring changes in the far-UV CD profiles of
the enzyme. In the far-UV region, the CD spectrum of native
SpnHL shows the presence of substantial -helical and -sheet
conformation. Fig. 2B summarizes the effect of increasing
GdnHCl concentration on loss of ellipticity at 222 nm for
SpnHL. Two well separated transitions, a sharp transition
between 0.4 and 0.75 M GdnHCl, and a broad transition be-
tween 0.9 and 2.2 M GdnHCl were observed. Furthermore, only
about 30% loss of secondary structure was found to be associ-
ated with the first transition indicating only partial unfolding
of SpnHL molecules under these conditions. However, at
GdnHCl concentrations greater than 2 M, a complete loss of
far-UV CD signal was observed suggesting complete unfolding
of SpnHL molecules at higher GdnHCl concentrations.
As only partial unfolding of SpnHL molecules was found to
be associated with the first transition observed at low GdnHCl
concentrations, it seems that probably only one of the struc-
tural domains of enzyme unfolds under these conditions
whereas the other domain remains intact. The thermal dena-
turation profile of 0.75 M GdnHCl-treated SpnHL further
strengthened this possibility as only a single transition with
mid-point of thermal transition (Tm) of about 40 °C was ob-
served for this sample (Fig. 2C).
CaCl2 Interaction with SpnHL Results in Unfolding of
Only One Domain
Calcium ions are essential for the normal enzymatic activity of
SpnHL (18, 23). It has been speculated that the calcium ions most
likely bind to the C-terminal domain of SpnHL and induce struc-
FIG. 3. Calcium chloride- and magnesium chloride-induced
changes in tertiary and secondary structure of SpnHL at 25 °C.
A, plot of changes in wavelength of maximum fluorescence emission of
tryptophan molecules in SpnHL at increasing concentration of CaCl2 or
MgCl2. The filled symbols represent data for CaCl2, and the open
symbols represent that for MgCl2. The enzyme was incubated at in-
creasing concentrations of CaCl2 or MgCl2 for 1 h at 25 °C, after which
the measurements were made. B, CaCl2- or MgCl2-induced changes in
secondary structure of SpnHL as monitored by following changes in the
CD ellipticity value at 222 nm. The data are represented as percentages
with the value observed for native enzyme in absence of CaCl2 or MgCl2
taken as 100%. The symbols are the same as in A.
FIG. 4. Characterization and purification of N-terminal do-
main of SpnHL. A, SDS-PAGE profile of native SpnHL and SpnHL
treated under various conditions on proteolysis with carboxypeptidase
B. Lanes 2-5 represent proteolytic fragments of SpnHL heated at 55 °C,
0.75 M GdnHCl-stabilized SpnHL, 1.5 M CaCl2-stabilized SpnHL, and
native SpnHL, respectively. Lane 1 represents protein standards of
molecular masses of 80 and 33 kDa. B, size exclusion profile on Super-
dex 75 HR column of the various fragments obtained on limited prote-
olysis of SpnHL by carboxypeptidase B as shown in A. The various
curves represent proteolytic fragments of native SpnHL (1), native
SpnHL heated at 55 °C (2), 0.75 M GdnHCl-stabilized SpnHL (3), 1.5 M
CaCl2-stabilized SpnHL (4), and 2.5 M GdnHCl-stabilized SpnHL (5).
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tural changes in the loop of the catalytic cleft (24). We studied the
effect of CaCl2 and MgCl2 on the domain structure of SpnHL.
The CaCl2- and MgCl2-induced alterations in the tertiary
structure of SpnHL were studied by monitoring the changes in
the tryptophan fluorescence of enzyme. Fig. 3A summarizes the
changes in the emission wavelength of tryptophan fluorescence
of SpnHL at increasing concentrations of CaCl2 and MgCl2. A
sigmoidal dependence of enhancement of emission wavelength
(from 334 to 341 nm) with increasing concentration of CaCl2 or
MgCl2 was observed. However, even at 1.5 M CaCl2 or MgCl2 an
emission wavelength of about 341 nm was observed suggesting
only partial unfolding of enzyme under these conditions (as
discussed under “GdnHCl Denaturation”). The far-UV CD
studies on SpnHL with increasing concentrations of CaCl2 or
MgCl2 also support the suggestion of partial unfolding of en-
zyme by these salts. Fig. 3B shows the loss of CD ellipticity at
222 nm of SpnHL with increasing concentration of CaCl2 or
MgCl2. A maximum of only about 30% loss of secondary struc-
ture was observed for CaCl2- or MgCl2-induced transition. As
CaCl2 or MgCl2 induces only partial unfolding of SpnHL mol-
ecules it seems that these salts probably induce unfolding of
only one of the structural domains of enzyme whereas the other
domain remains intact.
As GdnHCl (at low concentration), CaCl2, or MgCl2, which
are all electrolytes, induced partial unfolding of SpnHL, the
possibility of a nonspecific ion-induced effect on the enzyme
was also explored. For this, the effect of NaCl on structural
parameters of SpnHL was studied and is summarized in Fig. 2,
A and B. NaCl even up to 2 M concentration showed no signif-
icant change in the tryptophan fluorescence or to the secondary
structure of SpnHL indicating that NaCl does not induce any
change in enzyme structure probably because of lack of its
interaction with the enzyme. These observations collectively
suggest that GdnHCl, CaCl2, and MgCl2 have specific interac-
tion/binding sites with/in SpnHL.
Identification of Structural Domain Susceptible to Low
Temperature or Low GdnHCl Concentration or CaCl2
The factors determining the vulnerability for proteolysis of a
protein by protease depend on the conformational parameters
such as accessibility, segmental motion, and protrusions. For
this reason limited proteolysis has been effectively used to
monitor structural domains in proteins, ligand-induced confor-
mational changes, and protein folding/unfolding (25).
To characterize the structural domains corresponding to the
transitions observed during thermal-, GdnHCl-, and CaCl2-
induced unfolding of SpnHL (see Figs. 1–3) limited proteolysis
studies were carried out under conditions where only one tran-
sition was complete. Fig. 4A summarizes the SDS-PAGE profile
of the protein fragments obtained on limited proteolysis with
carboxypeptidase B of the SpnHL molecule heated at 55 °C or
treated with 0.75 M GdnHCl or 1.5 M CaCl2. For all three
samples, a single protein band corresponding to a molecular
mass of about 40 kDa was observed on proteolysis. There are
about 96 cleavage sites of Carboxypeptidase B spread through-
out the SpnHL molecule, including one in the linker region.
However, limited proteolysis of SpnHL by the protease in all
the conditions studied resulted in only a single fragment of
about 40 kDa. This suggests that the obtained fragment is a
folded one in which the proteolytic sites are buried in the
protein interior and not accessible to protease for cleavage. The
N-terminal amino acid sequencing of the 40-kDa fragments
were carried out following Western blotting of protein bands on
polyvinylidene difluoride membranes. In all the three cases the
nine amino acids obtained corresponded to the first nine resi-
dues (ASVKDTYTD) of the N-terminal domain of SpnHL.
These observations suggest that heating of the SpnHL mole-
cule to 55 °C or treating it with 0.75 M GdnHCl or 1.5 M CaCl2
results in unfolding of only the C-terminal domain. The N-
terminal domain of SpnHL obtained on limited proteolysis was
purified by size exclusion chromatography (Fig. 4B). For char-
acterization of the carboxypeptidase B cleavage site in SpnHL
that generates the N-terminal fragment on proteolysis, electro-
spray ionization mass spectrometry analysis of the N-terminal
fragments obtained were carried out. Only two peaks corre-
sponding to molecular massed of 40501 and 42414.5 Da with
relative intensity ratios of 3:1, respectively, were observed
(data not shown). As the major peak corresponded to a molec-
ular mass of 40501 Da, it suggests that the carboxypeptidase B
cleavage site in the SpnHL is between Tyr520 and Lys521. This
site is located at the end of N-terminal domain just before the
polypeptide linkers analyzed from the crystal structure.
FIG. 5. Thermal denaturation of N-
terminal fragment of SpnHL. The fig-
ure shows comparative mid-point of ther-
mal transition of isolated N-terminal
fragment purified by size exclusion chro-
matography as shown in Fig. 4B. The Tm
were obtained from the thermal unfolding
profiles of these samples measured by CD
ellipticity at 222 nm and is represented as
percentages with the value of these sam-
ples at 25 °C taken as 100% (inset). Num-
bers represent N-terminal domain in na-
tive SpnHL (Fig. 1) (1), N-terminal
domain obtained after proteolysis at
55 °C (circles in inset) (2), and N-terminal
domain obtained after proteolysis in the
presence of 0.75 M GdnHCl (triangles in
inset) (3).
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Characterization of N-terminal Domain
The size exclusion chromatographically purified N-terminal
domains of SpnHL (Fig. 4B) were analyzed for thermal stabil-
ity, GdnHCl denaturation, and enzymatic activity.
Thermal Stability—The thermal denaturation profiles of the
isolated N-terminal fragments were obtained by monitoring
loss of CD ellipticity at 222 nm with increasing temperature.
Fig. 5 summarize the Tm observed for the isolated N-terminal
domain obtained on limited proteolysis of SpnHL at 55 °C and
on treatment with 0.75 M GdnHCl. A single transition with the
Tm of about 76 and 75 °C was observed for the two samples,
which is very close to the Tm of 82 °C (Fig. 1) observed for
N-terminal domain in the native enzyme. This observation
demonstrates that the fragments obtained on proteolysis of
SpnHL (Fig. 4B) are intact N-terminal domains. Furthermore,
it also demonstrates that the stability of N-terminal domain
was not affected by removal of C-terminal domain suggesting
the absence of cooperative interactions between the two do-
mains of SpnHL.
GdnHCl Denaturation—The GdnHCl denaturation profile of
the purified N-terminal domain obtained on limited proteolysis
of SpnHL at 55 °C and on treatment with 0.75 M GdnHCl was
studied using tryptophan fluorescence and far-UV CD spectros-
copies and is summarized in Fig. 6. The alterations in the
tertiary structure of N-terminal fragment of SpnHL were mon-
itored by studying the changes in the tryptophan fluorescence
at increasing concentration of GdnHCl. When fractional
change in emission wavelength at which the fluorescence in-
tensity of N-terminal fragment of SpnHL is maximal is plotted
against the increasing concentration of GdnHCl, a sigmoidal
transition in the GdnHCl concentration range between 0.5 and
2 M was observed (Fig. 6A). A Cm (denaturant concentration
where 50% denaturation of protein is observed) of about 1.25 M
GdnHCl was found to be associated with this transition.
The effect of GdnHCl on the secondary structure of N-termi-
nal fragment of SpnHL was studied by monitoring changes in
the far-UV CD profiles of the enzyme. The CD spectrum of
N-terminal fragment of SpnHL in the far-UV region shows the
presence of substantial -helical conformation. Fig. 6B summa-
rizes the effect of increasing GdnHCl concentration on the loss
of ellipticity at 222 nm for N-terminal fragment of SpnHL. A
single transition in the GdnHCl concentration range between
0.5 and 2 M was observed. A Cm of about 1.25 M GdnHCl was
found to be associated with this transition. As for both trypto-
phan fluorescence and far-UV CD, a single transition between
0.5 and 2 M GdnHCl was observed, which suggests that the
FIG. 6. Guanidine hydrochloride-induced unfolding of N-ter-
minal fragment of SpnHL obtained on limited proteolysis of
SpnHL at 55 °C. A, plot of fractional changes in wavelength of maxi-
mum fluorescence emission of tryptophan molecules in N-terminal frag-
ment of SpnHL, (fi  f0)/(fd  f0), versus GdnHCl concentration. The
studies were carried out at 25 °C. B, GdnHCl-induced changes in sec-
ondary structure of N-terminal fragment of SpnHL as monitored by
following changes in the CD ellipticity value at 222 nm. The data are
represented as percentages with the value observed for enzymes in the
absence of GdnHCl taken as 100%. The studies were carried out at
25 °C. C, thermal unfolding of 0.75 M GdnHCl-treated N-terminal frag-
ment of SpnHL measured by CD ellipticity at 222 nm. The data are
represented as percentages with the value observed for 0.75 M GdnHCl
at 20 °C taken as 100%. The enzyme was incubated in 0.75 M GdnHCl
for 1 h at 20 °C, after which the measurements were made.
FIG. 7. Enzymatic activity of the N-terminal fragment of
SpnHL. The figure shows comparative enzymatic activity of native
SpnHL and isolated N-terminal fragment purified by size exclusion
chromatography as shown in Fig. 4B. The numbers correspond to native
enzyme (1), N-terminal domain obtained after proteolysis at 55 °C (2),
N-terminal domain obtained after proteolysis in the presence of 0.75 M
GdnHCl (3), and N-terminal domain obtained after proteolysis in the
presence of 1.5 M CaCl2 (4). The enzymatic activity is represented in
percentages with that corresponding to native SpnHL taken as 100%.
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N-terminal fragment of SpnHL undergoes a cooperative unfold-
ing with simultaneous loss of both the secondary and the ter-
tiary structure.
The thermal denaturation profile of N-terminal fragment of
SpnHL obtained as described above, treated with 0.75 M
GdnHCl, was studied. A single transition with a Tm of about
40 °C (Fig. 6C) was observed, which is similar to that observed
for the 0.75 M GdnHCl-treated SpnHL (Fig. 2C).
In native SpnHL, for the second transition observed at
higher concentrations of GdnHCl, a Cm of about 1.25 M was
observed by both tryptophan fluorescence and far-UV CD (Fig.
2, A and B), which is similar to that reported above for the
purified N-terminal fragment of SpnHL. These observations
lend further support to the contention that the N-terminal
fragments obtained on limited proteolysis of SpnHL treated
under specified conditions is in folded conformation.
N-terminal Domain Is the Functional Domain Capable of
Carrying Out Enzymatic Reaction on Its Own
The reported structure of SpnHL in complex with hyaluronic
acid (16) showed that the three residues, Tyr408, His399, and
Asn349, from N-terminal domain and HA are perfectly placed to
support the mechanism of HA degradation (14, 16). This indi-
cates that probably the C-terminal domain does not play any
significant role in the enzymatic activity of SpnHL. This pos-
sibility is further supported by the evidence from some struc-
turally related enzyme like glucoamylase (26) and alginate
lyase (27) in which only the -domain is present.
As we were able to obtain an intact N-terminal domain of
SpnHL we carried out enzymatic activity measurements of this
domain. Fig. 7 summarizes the comparison of enzymatic activ-
ity of isolated N-terminal domain with that of the native en-
zyme. The N-terminal domain showed about 12% enzymatic
activities compared with the native enzyme. This demonstrates
that the N-terminal domain is the functional domain of SpnHL
and is itself sufficient for carrying out the enzymatic reaction.
The C-terminal domain seems to modulate the enzymatic ac-
tivity probably by holding the substrate, hyaluronic acid, in a
suitable conformation for enzymatic reaction as speculated ear-
lier (14).
Inhibitors of SpnHL
The degradation of hyaluronan in the connective tissues by
SpnHL is an important step in the pneumococcal invasion. The
bacterial strains producing more hyaluronate lyase are more
virulent than those strains producing less enzyme (28). Fur-
thermore, S. pneumoniae strains with SpnHL and cell toxin
pneumolysin double mutations showed significant additive at-
tenuation in virulence (29). Therefore, the inhibition of SpnHL
is expected to reduce the spreading of S. pneumoniae pathogen
in the early stages of the pneumococcal invasion. Furthermore,
hyaluronate lyase from bacteria and Streptomyces differ from
hyaluronidases from other sources, including mammals, by
their mode of action. They catalyze an elimination reaction,
rather than hydrolysis of the 1,4-glycosidic linkage between
N-acetyl--D-glucosamine and D-glucuronic acid residues in
hyaluronan. Because of these reasons SpnHL becomes a poten-
tial target for developing antimicrobial agents.
Salicylate, vitamin C, heparin, dicumarene, and flavonoids
have been reported to have certain inhibitory effects on the
enzyme activity of hyaluronidase (5). However, recent studies
by Li et al. (17) have reported that of the above mentioned
molecules only vitamin C inhibits SpnHL activity. They also
reported the crystal structure of SpnHLvitamin C complex
FIG. 8. Enzyme activity of SpnHL in the presence of GdnHCl (A), L-arginine (B), L-NAME (C), and GdnHSCN (D). Each point
represents averaged value for four parallel measurements. The experimental details are given under “Experimental Procedures.”
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(17), which shows that only one vitamin C molecule binds to
SpnHL at the active site and forms about 25 interactions with
seven residues (mainly from N-terminal domain and only one
from C-terminal domain) of SpnHL.
The structural studies on SpnHL presented in this paper
demonstrated that GdnHCl interacts with enzyme and induces
significant structural changes in it. As the active site of an
enzyme is very susceptible to subtle adjustments or conforma-
tional variations in the enzyme we thought it worthwhile to
study the effect of GdnHCl and some related molecules (having
guanidino moiety) on the enzyme activity of SpnHL so that
their efficiency as inhibitors can be explored. Fig. 8 summa-
rizes the effect of increasing concentrations of GdnHCl, L-argi-
nine, L-NAME, and GdnHSCN on the inhibition of enzymatic
activity of SpnHL. All four molecules inhibited the SpnHL
activity in a dose-dependent manner. The IC50 of enzyme ac-
tivity by GdnHCl, L-arginine, L-NAME, and GdnHSCN was
found to be 150, 8.0, 0.85, and 0.14 mM, respectively. The
interesting observation is that at the concentration of GdnHCl
at which there is complete inhibition of SpnHL activity (about
350 mM), no significant effect on structural properties of en-
zyme was observed (Fig. 2). Similar observations were obtained
for GdnHSCN, L-NAME, and L-arginine (data not shown).
These observations suggest that GdnHCl or L-arginine or L-
NAME and GdnHSCN affect the active site of enzyme at a
concentration much lower than that required for bringing out
any significant structural change in enzyme. This is possible
only if these molecules bind directly to the active site first,
followed by binding to other sites in the enzyme, which results
in structural changes. For vitamin C, which has been reported
as an inhibitor of SpnHL, an IC50 of 5.8 mM was observed
(17). In the present study an IC50 of 0.85 and 0.14 mM were
observed for L-NAME and GdnHSCN, respectively, which are
significantly lower (about seven and 40 times) than vitamin C.
These studies present a new chemical entity that can be ex-
ploited for better designing of inhibitors for SpnHL.
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